BIH PATHOLOGY FOUNDATION INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1984

Legal Domicile

Principal Officer

MICHAEL ROEHRL

Phone

6176674344

Tax Period

2023-10-01 to 2024-09-30

BIH PATHOLOGY FOUNDATION INC, founded in 1984, is a small nonprofit that reported $308K in total revenue in fiscal year 2023. Revenue surged 25% from the prior year, signaling strong growth momentum. Expenses of $970K exceeded revenue, resulting in a 215% operating deficit.

Mission

THE MISSION OF BIH PATHOLOGY FOUNDATION, INC. (THE FOUNDATION) IS TO SUPPORT THE PATIENT CARE, RESEARCH, AND TEACHING MISSIONS OF BETH ISRAEL DEACONESS MEDICAL CENTER (BIDMC) AND HARVARD MEDICAL FACULTY PHYSICIANS AT BETH ISRAEL DEACONESS MEDICAL CENTER (HMFP) AS WELL AS TO SUPPORT TEACHING AND RESEARCH AT THE PRESIDENT AND FELLOWS AT HARVARD COLLEGE/HARVARD MEDICAL SCHOOL (HMS).

Program Service Accomplishments

Program 1

Expenses: $882,041

SUPPORT MEDICAL AND OTHER TYPES OF RESEARCH AT BETH ISRAEL DEACONESS MEDICAL CENTER AND HARVARD MEDICAL FACULTY PHYSICIANS AT BETH ISRAEL DEACONESS MEDICAL CENTER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $308,020

Other Revenue $0

TOTAL REVENUE $308,020

Expense Breakdown

Grants Paid $882,041

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $882,041

Other Expenses $87,640

TOTAL EXPENSES $969,681

Year-over-Year Comparison

	2023	2022	Change
Revenue	$308,020	$246,639	+0.2%
Expenses	$969,681	$551,839	+0.8%
Net Income	$-661,661	$-305,200	+1.2%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,573,394

Total Directors

$2,732,033

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ROEHRL MD MICHAEL	DIR(EX-OFF) & PRES; PATH CHIEF/CHAIR	1.00	Officer Director	$0	$71,970	$649,100
UHL MD LYNNE	DIR (CHIEF DIV LAB & TRANSFUS BIDMC)	1.00	Director	$0	$79,156	$499,635
COLLINS MD LAURA	DIRECTOR & CLERK; PATHOLOGIST	1.00	Officer Director	$0	$65,971	$492,243
VANDERLAAN MD PHD PAUL	DIR; DIR SURG PATH & CYTOLOGY BIDMC	1.00	Director	$0	$57,422	$396,843
KIRBY MD JAMES E	DIRECTOR; PATHOLOGIST	1.00	Director	$0	$38,773	$349,624
RIEDEL MD STEFAN	DIRECTOR; PATHOLOGIST	1.00	Director	$0	$79,621	$344,588
MURPHY PAMELA	TREAS & CHIEF ADMINISTRATIVE OFFICER	1.00	Officer	$0	$81,871	$432,051
SAFFITZ MD PHD JEFFREY E	FMR DIR & PRES; FMR PATH CHIEF/CHAIR	0.00		$0	$75,129	$810,714

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$308,020	$969,681	$14,394,832	$-661,661
2023	$246,639	$551,839	$12,331,997	$-305,200
2022	$399,825	$627,903	$10,727,499	$-228,078
2021	$1,097,685	$585,747	$11,873,178	$511,938
2020	$334,428	$611,604	$9,855,904	$-277,176
2019	$367,553	$543,613	$9,670,909	$-176,060
2018	$322,377	$143,267	$9,488,089	$179,110